Global Anti- Worm Medication Market Size, Share and Trends Analysis Report, by Type (Albenza and Vermox), and By Application (Human and Veterinary), Forecast Period (2022-2028)

The global anti-worm medication market is anticipated to grow at a CAGR of 5.0% during the forecast period (2022-2028). Anti-worm medication is used to treat worm infections like whipworm, pinworm, roundworm, and hookworm. Abdominal pain or tenderness, nausea, weakness, or diarrhea is all symptoms of worm infections. Mebendazole and albendazole are two medications that kill worms by starving or paralyzing them. They function by stopping the worms from absorbing the glucose they need to survive. The goal of the anti-worm medication is to minimize infection severity. One of the primary factors driving the market growth is the increase in the prevalence of worm infection. There as many reasons for getting a worm infection such as touching objects or surfaces with worm eggs on them, walking barefoot on soil containing worms, consuming raw or undercooked meat, pork, or young worm-infested freshwater fish (such as salmon or trout). Due to the negligence of the above-mentioned factors, a person is likely to get infected by worm infection.

 

Market expansion is fuelled by rising innovations and expanded medication research and development efforts. For instance, in February 2021, Bayer AG launched the Vayego solution which is a liquid formula containing tetraniliprole. It provides effective Lepidopteran control including worms in a variety of crops, including rice, vegetables, and plantation crops, while posing little damage to beneficial insects as it belongs to the GHS5 group. Additionally, in May 2021, Bajaj Healthcare announced the launch of Ivejaj, Ivermectin is contained in the IVEJAJ tablets. Ivermectin is an anti-parasitic drug that helps to improve the health of Covid-19 patients by controlling parasitic roundworm infections and curing parasitic diseases.

 

The market’s growth is fuelled by the ease of direct buying, as well as strong adoption and acceptability. To combat the rising occurrence of worm infections, companies are developing a variety of innovative formulations and solutions for the anti-worm medication market. For instance,  In April 2021, Dr. Reddy’s Labs announces the launch of Albendazole tablets in the US. It is used for the treatment of cystic hydatid disease of the liver, lung, and peritoneum that is caused by the larval form of the dog tapeworm. The global anti- worm market is predicted to increase in response to rising awareness about treating infection through advertisements. Furthermore, the growing prevalence of parasite infestation in pets, livestock, and other animals has created lucrative growth potential for the anti-worm medication market.

 

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape- Bayer AG, Boehringer Ingelheim International GmbH., Dechra Pharmaceuticals, GlaxoSmithKline Plc.,  Zoetis, among others.

 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

 

Global Anti-Worm Medication Market Report by Segment

By Type

• Albenza
• Vermox

By Application

• Human
• Veterinary

 

Global Anti-Worm Medication Market Report by Region

North America

• US
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa